PURPOSE: To investigate the association between VEGF gene polymorphism and age-related macular degeneration (AMD) in a Brazilian cohort. METHODS: We examined 160 affected individuals and 140 sex- and age-matched controls recruited at the Vision Institute and the Retina Department, São Geraldo Hospital, Minas Gerais Federal University, Brazil, between 2007 and 2011. Genotyping for the VEGF rs1413711 single nucleotide polymorphism (SNP) (+674C>T) was performed. The incidence rate ratios and 95% confidence interval (CI) for AMD for this genotype was calculated. The odds ratio (OR) was also assessed by using logistic regression, controlling for CFH and LOC387715 risk genotype. RESULTS: We observed a prevalence of homozygosity (TT genotype) of 18.1% for rs1413711 among AMD cases compared with 5.8% among controls (P < 0.002). The ORs for this polymorphism were 3.6 (95%CI 1.6-8.2) for homozygous subjects and 1.5 (95%CI 1.1-2.1, P < 0.01) if the subject had at least one risk allele. When we studied separately exudative and dry AMD groups, this polymorphism was statistically significant for both groups. Controlling for CFH and LOC387715 risk genotype the OR was 3.0 for VEGF homozygous, and the OR increases if the patient is homozygous for the three genes. CONCLUSION: The present data suggests that VEGF TT genotype is associated with AMD among Brazilian patients.
PURPOSE: To investigate the association between VEGF gene polymorphism and age-related macular degeneration (AMD) in a Brazilian cohort. METHODS: We examined 160 affected individuals and 140 sex- and age-matched controls recruited at the Vision Institute and the Retina Department, São Geraldo Hospital, Minas Gerais Federal University, Brazil, between 2007 and 2011. Genotyping for the VEGFrs1413711 single nucleotide polymorphism (SNP) (+674C>T) was performed. The incidence rate ratios and 95% confidence interval (CI) for AMD for this genotype was calculated. The odds ratio (OR) was also assessed by using logistic regression, controlling for CFH and LOC387715 risk genotype. RESULTS: We observed a prevalence of homozygosity (TT genotype) of 18.1% for rs1413711 among AMD cases compared with 5.8% among controls (P < 0.002). The ORs for this polymorphism were 3.6 (95%CI 1.6-8.2) for homozygous subjects and 1.5 (95%CI 1.1-2.1, P < 0.01) if the subject had at least one risk allele. When we studied separately exudative and dry AMD groups, this polymorphism was statistically significant for both groups. Controlling for CFH and LOC387715 risk genotype the OR was 3.0 for VEGF homozygous, and the OR increases if the patient is homozygous for the three genes. CONCLUSION: The present data suggests that VEGF TT genotype is associated with AMD among Brazilian patients.
Authors: Alessandro Galan; Alberto Ferlin; Luigi Caretti; Genny Buson; Giovanni Sato; Anna Chiara Frigo; Carlo Foresta Journal: Ophthalmology Date: 2010-05-14 Impact factor: 12.079
Authors: Jonathan L Haines; Nathalie Schnetz-Boutaud; Silke Schmidt; William K Scott; Anita Agarwal; Eric A Postel; Lana Olson; Shannon J Kenealy; Michael Hauser; John R Gilbert; Margaret A Pericak-Vance Journal: Invest Ophthalmol Vis Sci Date: 2006-01 Impact factor: 4.799
Authors: Katarzyna Janik-Papis; Malgorzata Zaras; Anna Krzyzanowska; Katarzyna Wozniak; Janusz Blasiak; Jerzy Szaflik; Jacek P Szaflik Journal: Exp Mol Pathol Date: 2009-09-15 Impact factor: 3.362
Authors: Luciana Negrão Frota de Almeida; Rachel Melilo Carolino; Diogo Cazelli Sperandio; Márcio Bittar Nehemy; L A De Marco Journal: Arq Bras Oftalmol Date: 2009 Jul-Aug Impact factor: 0.872
Authors: Johanna M Seddon; Robyn Reynolds; Julian Maller; Jesen A Fagerness; Mark J Daly; Bernard Rosner Journal: Invest Ophthalmol Vis Sci Date: 2008-12-30 Impact factor: 4.799
Authors: Gaofeng Wang; Kylee L Spencer; Brenda L Court; Lana M Olson; William K Scott; Jonathan L Haines; Margaret A Pericak-Vance Journal: Invest Ophthalmol Vis Sci Date: 2009-02-28 Impact factor: 4.799
Authors: Stephanie A Hagstrom; Gui-shuang Ying; Gayle J T Pauer; Gwen M Sturgill-Short; Jiayan Huang; Maureen G Maguire; Daniel F Martin Journal: JAMA Ophthalmol Date: 2014-05 Impact factor: 7.389
Authors: John Paul SanGiovanni; Jing Chen; Przemyslaw Sapieha; Christopher M Aderman; Andreas Stahl; Traci E Clemons; Emily Y Chew; Lois E H Smith Journal: PLoS One Date: 2013-01-15 Impact factor: 3.240